相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Design, synthesis and biological evaluation of novel diarylacylhydrazones derivatives for the efficient treatment of idiopathic pulmonary fibrosis
Xingping Su et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)
Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges
Mahshid Deldar Abad Paskeh et al.
PHARMACOLOGICAL RESEARCH (2023)
Hepatocytes infected with hepatitis C virus change immunological features in the liver microenvironment
Soo-Jeung Park et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2023)
Fibrotic immune microenvironment remodeling mediates superior anti-tumor efficacy of a nano-PD-L1 trap in hepatocellular carcinoma
Xiaoyu Liu et al.
MOLECULAR THERAPY (2023)
Current Perspectives on the Immunosuppressive Niche and Role of Fibrosis in Hepatocellular Carcinoma and the Development of Antitumor Immunity
Tomoko Aoki et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2022)
Dual inhibition of TGF-β and PD-L1: a novel approach to cancer treatment
James L. Gulley et al.
MOLECULAR ONCOLOGY (2022)
Anti-PD-L1 antibody alleviates pulmonary fibrosis by inducing autophagy via inhibition of the PI3K/Akt/mTOR pathway
Ye Lu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2022)
Gastric cancer cell-derived extracellular vesicles elevate E2F7 expression and activate the MAPK/ERK signaling to promote peritoneal metastasis through the delivery of SNHG12
Fangbin Zhang et al.
CELL DEATH DISCOVERY (2022)
Outcomes of gynecologic cancer surgery during the COVID-19 pandemic: an international, multicenter, prospective CovidSurg-Gynecologic Oncology Cancer study
Christina Fotopoulou et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2022)
The role of PD-1/PD-L1 axis in idiopathic pulmonary fibrosis: Friend or foe?
Aimin Jiang et al.
FRONTIERS IN IMMUNOLOGY (2022)
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor
Wenxian Wang et al.
THORACIC CANCER (2022)
PD-L1 Activity Is Associated with Partial EMT and Metabolic Reprogramming in Carcinomas
Srinath Muralidharan et al.
CURRENT ONCOLOGY (2022)
SNAIL Induces EMT and Lung Metastasis of Tumours Secreting CXCL2 to Promote the Invasion of M2-Type Immunosuppressed Macrophages in Colorectal Cancer
Zhen Bao et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)
Regulatory Effect of PD1/PD-Ligand 1 (PD-L1) on Treg Cells in Patients with Idiopathic Pulmonary Fibrosis
Bing Wang et al.
MEDICAL SCIENCE MONITOR (2021)
Curcumin Targets p53-Fibrinolytic System in TGF-BETA1 Mediated Alveolar Epithelial Mesenchymal Transition in Alveolar Epithelial Cells
Sadiya Bi Shaikh et al.
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2021)
Direct and Indirect Regulators of Epithelial-Mesenchymal Transition-Mediated Immunosuppression in Breast Carcinomas
Anushka Dongre et al.
CANCER DISCOVERY (2021)
Dasatinib and PD-L1 inhibitors provoke toxicity and inhibit angiogenesis in the embryo
Maha Al-Asmakh et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Liver fibrosis promotes immune escape in hepatocellular carcinoma via GOLM1-mediated PD-L1 upregulation
Meng-yun Ke et al.
CANCER LETTERS (2021)
Immunosuppressive Traits of the Hybrid Epithelial/Mesenchymal Phenotype
Sarthak Sahoo et al.
FRONTIERS IN IMMUNOLOGY (2021)
Polyphenols Modulating Effects of PD-L1/PD-1 Checkpoint and EMT-Mediated PD-L1 Overexpression in Breast Cancer
Samia S. Messeha et al.
NUTRIENTS (2021)
PD-L1 tumor-intrinsic signaling and its therapeutic implication in triple-negative breast cancer
Chunhua Chen et al.
JCI INSIGHT (2021)
Blockade of Autophagy Prevents the Development and Progression of Peritoneal Fibrosis
Yingfeng Shi et al.
FRONTIERS IN PHARMACOLOGY (2021)
Inflammatory macrophages switch to CCL17-expressing phenotype and promote peritoneal fibrosis
Yi-Ting Chen et al.
JOURNAL OF PATHOLOGY (2020)
Transforming growth factor beta induces fibroblasts to express and release the immunomodulatory protein PD-L1 into extracellular vesicles
Jeong-Han Kang et al.
FASEB JOURNAL (2020)
PDL1 blockage increases fetal resorption and Tfr cells but does not affect Tfh/Tfr ratio and B-cell maturation during allogeneic pregnancy
Weihong Zeng et al.
CELL DEATH & DISEASE (2020)
Trophoblast-secreted soluble-PD-L1 modulates macrophage polarization and function
Yong-Hong Zhang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2020)
Study on the relationship between hepatic fibrosis and epithelial-mesenchymal transition in intrahepatic cells
Yang Chen et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Activation of JUN in fibroblasts promotes pro-fibrotic programme and modulates protective immunity
Lu Cui et al.
NATURE COMMUNICATIONS (2020)
Immune-related signature predicts the prognosis and immunotherapy benefit in bladder cancer
Yejinpeng Wang et al.
CANCER MEDICINE (2020)
Role of PD-L1 in Gut Mucosa Tolerance and Chronic Inflammation
Marina Chulkina et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems
Sai Balaji Andugulapati et al.
PHYTOMEDICINE (2020)
The importance of exosomal PDL1 in tumour immune evasion
Dhouha Daassi et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Low miR200c expression in tumor budding of invasive front predicts worse survival in patients with localized colon cancer and is related to PD-L1 overexpression
Carolina Martinez-Ciarpaglini et al.
MODERN PATHOLOGY (2019)
Common Pathogenic Mechanisms Between Idiopathic Pulmonary Fibrosis and Lung Cancer
Argyris Tzouvelekis et al.
CHEST (2019)
Phospho-STAT1 expression as a potential biomarker for anti-PD-1/anti-PD-L1 immunotherapy for breast cancer
Yuko Nakayama et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2019)
Targeting the YB-1/PD-L1 Axis to Enhance Chemotherapy and Antitumor Immunity
Zhen Tao et al.
CANCER IMMUNOLOGY RESEARCH (2019)
PD-1hi CD8+ resident memory T cells balance immunity and fibrotic sequelae
Zheng Wang et al.
SCIENCE IMMUNOLOGY (2019)
Exogenous angiotensin (1-7) directly inhibits epithelial-mesenchymal transformation induced by transforming growth factor-β1 in alveolar epithelial cells
Min Shao et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
A Gallbladder Carcinoma Patient With Pseudo-Progressive Remission After Hydrogen Inhalation
Jibing Chen et al.
ONCOTARGETS AND THERAPY (2019)
Magnesium isoglycyrrhizinate ameliorates high fructose-induced liver fibrosis in rat by increasing miR-375-3p to suppress JAK2/STAT3 pathway and TGF-β1/Smad signaling
Yan-zi Yang et al.
ACTA PHARMACOLOGICA SINICA (2019)
Pterostilbene prevents hepatocyte epithelial-mesenchymal transition in fructose-induced liver fibrosis through suppressing miR-34a/Sirt1/p53 and TGF-β1/Smads signalling
Lin Song et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
PD-1 immunobiology in systemic lupus erythematosus
Colleen S. Curran et al.
JOURNAL OF AUTOIMMUNITY (2019)
Characterization of CD28null T cells in idiopathic pulmonary fibrosis
David M. Habiel et al.
MUCOSAL IMMUNOLOGY (2019)
PD-L1 on invasive fibroblasts drives fibrosis in a humanized model of idiopathic pulmonary fibrosis
Yan Geng et al.
JCI INSIGHT (2019)
EGFR activation induced Snail-dependent EMT and myc-dependent PD-L1 in human salivary adenoid cystic carcinoma cells
Yang Wang et al.
CELL CYCLE (2018)
Prognostic impact of programmed cell death ligand 1 (PD-L1) expression and its association with epithelial-mesenchymal transition in extrahepatic cholangiocarcinoma
Takashi Ueno et al.
Oncotarget (2018)
Pirfenidone suppresses TGF-1-induced human intestinal fibroblasts activities by regulating proliferation and apoptosis via the inhibition of the Smad and PI3K/AKT signaling pathway
Yanwu Sun et al.
MOLECULAR MEDICINE REPORTS (2018)
PD-1 up-regulation on CD4+ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production
Lindsay J. Celada et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Regulation of GVHD and GVL Activity via PD-L1 Interaction With PD-1 and CD80
Kaniel Cassady et al.
FRONTIERS IN IMMUNOLOGY (2018)
PD-L1 and c-MET expression and survival in patients with small cell lung cancer
Lulu Miao et al.
ONCOTARGET (2017)
PD-L1 Expression in Pancreatic Cancer
Lei Zheng
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Therapy-induced E-cadherin downregulation alters expression of programmed death ligand-1 in lung cancer cells
Kenichi Suda et al.
LUNG CANCER (2017)
PD-L1 Expression in Pancreatic Cancer
Lei Zheng
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
PD-L1 Expression Promotes Epithelial to Mesenchymal Transition in Human Esophageal Cancer
Lujun Chen et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Epstein-Barr Virus-associated Gastric Cancer and Potential Mechanisms of Oncogenesis
Abigail Morales-Sanchez et al.
CURRENT CANCER DRUG TARGETS (2017)
EMT transcription factors in cancer development re-evaluated: Beyond EMT and MET
Steven Goossens et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2017)
Farnesyltransferase inhibitor FTI-277 inhibits PD-L1 expression on septic spleen lymphocytes and promotes spleen lymphocyte activation
W. Li et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2017)
Epithelial-to-Mesenchymal Transition Contributes to Immunosuppression in Breast Carcinomas
Anushka Dongre et al.
CANCER RESEARCH (2017)
Programmed death-ligand 1 expression at tumor invasive front is associated with epithelial-mesenchymal transition and poor prognosis in esophageal squamous cell carcinoma
Satoshi Tsutsumi et al.
CANCER SCIENCE (2017)
Epithelial-Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma
Yanyan Lou et al.
CLINICAL CANCER RESEARCH (2016)
PD-L1 expression is associated with epithelial-to-mesenchymal transition in adenocarcinoma of the lung
Sehui Kim et al.
HUMAN PATHOLOGY (2016)
Attenuation of the programmed cell death-1 pathway increases the M1 polarization of macrophages induced by zymosan
W. Chen et al.
CELL DEATH & DISEASE (2016)
Molecular Mechanisms Underlying Peritoneal EMT and Fibrosis
Raffaele Strippoli et al.
STEM CELLS INTERNATIONAL (2016)
PD-L1 induces epithelial-to-mesenchymal transition via activating SREBP-1c in renal cell carcinoma
Yiwei Wang et al.
MEDICAL ONCOLOGY (2015)
Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: Significance in claudin-low breast cancer cells
Abdullah Alsuliman et al.
MOLECULAR CANCER (2015)
FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cells
LaTonia Taliaferro-Smith et al.
ONCOTARGET (2015)
Programmed death-1/programmed death-L1 signaling pathway and its blockade in hepatitis C virus immunotherapy
Mohamed L. Salem et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Tuning of Antigen Sensitivity by T Cell Receptor-Dependent Negative Feedback Controls T Cell Effector Function in Inflamed Tissues
Tetsuya Honda et al.
IMMUNITY (2014)
Epithelial-to-Mesenchymal Transition and Autophagy Induction in Breast Carcinoma Promote Escape from T-cell-Mediated Lysis
Intissar Akalay et al.
CANCER RESEARCH (2013)
CCL2 is critical for immunosuppression to promote cancer metastasis
Chie Kudo-Saito et al.
CLINICAL & EXPERIMENTAL METASTASIS (2013)
Inhibition of PI3K Prevents the Proliferation and Differentiation of Human Lung Fibroblasts into Myofibroblasts: The Role of Class I P110 Isoforms
Enrico Conte et al.
PLOS ONE (2011)
Role for α3 integrin in EMT and pulmonary fibrosis
Zea Borok
JOURNAL OF CLINICAL INVESTIGATION (2009)
Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients:: Pathologic significance and potential therapeutic interventions
Luiz S. Aroeira et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Transient overexpression of TGF-β1 induces epithelial mesenchymal transition in the rodent peritoneum
PJ Margetts et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Smad3 as a mediator of the fibrotic response
KC Flanders
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2004)
Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice
MC Yu et al.
HEPATOLOGY (2004)
分享论文
